SEC Form 4Coverage since Jun 8, 2026
$MDT insider trading
Over the last 12 months, Medtronic insiders reported no purchases and 2 sales totaling $595K across SEC Form 4 filings. 50% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $595K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 50% pre-arranged plans
Side
Price · $MDT · 12Mvia TradingView
Top insiders · 12m
Walter Matthew R.SVP, Chief HR Officer1× · $258K
KIIL HARRY SKIPEVP & President Cardiovascular1× · $337K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Walter Matthew R.SVP, Chief HR Officer · O | ▼ Sale | 3,102 | $83.15 | $258K | -8% | plan |
| Jun 8, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular · O | ▼ Sale | 4,189 | $80.44 | $337K | -10.1% | 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MDT feed.